Clinical Trial Update: A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the pharmacokinetics and pharmacodynamics of SAR342434 compared with insulin lispro in subjects with Type 1 diabetes. The trial has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• SAR342434
• insulin lispro (insulin lispro)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED